San Diego, CA, United States of America

Gang Chen

USPTO Granted Patents = 53 

 

Average Co-Inventor Count = 6.5

ph-index = 10

Forward Citations = 296(Granted Patents)

Forward Citations (Not Self Cited) = 266(Dec 10, 2025)


Location History:

  • Los Angeles, CA (US) (2010 - 2015)
  • Redondo Beach, CA (US) (2013 - 2015)
  • Rancho Palos Verdes, CA (US) (2015 - 2021)
  • San Diego, CA (US) (2009 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Radiolabelled MGL PET Ligands
Azabenzimidazoles
PSMA Imaging Agents
Monoacylglycerol Lipase Modulators
Antibody Drug Conjugates
Substituted 1,2,3-Triazoles
Cyclic Azapeptides
Imaging Agents
Anti-Angiogenic Compounds
Molecular Imaging Probes
IL-1 Binding Antibodies
Neurological Dysfunction
53 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Gang Chen Revolutionizing Pharmaceutical Treatments

Introduction

Gang Chen is a prolific inventor based in San Diego, CA (US) known for his groundbreaking work in the field of pharmaceuticals. With an impressive portfolio of 47 patents, his innovative contributions have significantly impacted the healthcare industry.

Latest Patents

Among his latest patents, Gang Chen has developed Monoacylglycerol lipase modulators - Bridged compounds and pharmaceutical compositions that offer new methods for treating a wide range of disease states. Additionally, his work on Drug-conjugates with a targeting molecule and two different drugs has paved the way for improved ADC compositions, enhancing drug delivery systems in targeted therapy.

Career Highlights

Gang Chen's expertise has been instrumental in leading research and development efforts at prominent companies such as Siemens Medical Solutions USA, Inc. and Xoma Technology Ltd. His visionary approach to drug development has redefined standards in the pharmaceutical sector, earning him recognition as a pioneer in the field.

Collaborations

Throughout his career, Gang Chen has collaborated closely with accomplished professionals in the industry, including Dhanalakshmi Kasi and Joseph C Walsh. Together, they have spearheaded innovative projects, driving advancements in drug discovery and therapeutic interventions.

Conclusion

In conclusion, Gang Chen's unwavering dedication to scientific excellence and his pioneering spirit have positioned him as a key player in revolutionizing pharmaceutical treatments. His relentless pursuit of innovation continues to inspire the next generation of inventors and researchers in the quest for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…